AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Biotage

Report Publication Announcement Apr 6, 2011

2894_rns_2011-04-06_ffd53cfa-cd18-4b8c-91bf-bc2547d60e2d.pdf

Report Publication Announcement

Open in Viewer

Opens in native device viewer

- -

  • !"- #- \$\$% &'()) &')'()'# - *+ - ,* *

  • /)

- -

0 -1 -\$ 2'/#(34('#35*

0 - -65 -\$ /#34)#5 \$ - 2 2- 765 2 - 0 1- 2'#/34#5*

  • 2 - 0-65 2)#'4)#5* 65 7\$ .- \$ . 2 \$. . 0'''#3

0 2 - - 8 ...* * -

The information in this press release is of the kind that Biotage AB (publ) may be required to make public according to the Securities Market Act and/or Financial Instruments Trading Act. The information was released for publication at 8.30 am on April 6, 2011.

About Biotage:

Biotage offers solutions, knowledge and experience in the areas of analytical chemistry and medicinal chemistry. The customers include the world's largest pharmaceutical and biotech companies, and leading academic institutes. The company is headquartered in Uppsala and has subsidiaries in the US, UK and Japan. Biotage has 272 employees and had sales of 428.9 MSEK in 2010. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website:www.biotage.com

  • ...* * -

Talk to a Data Expert

Have a question? We'll get back to you promptly.